12(S)-Hydroxyeicosatetraenoic acid [12(S)-HETE] is the 12-lipoxygenase
metabolite of arachidonic acid. Previously, we have demonstrated that
exogenous 12(S)-HETE can activate protein kinase C, increase cell sur
face expression of integrins, enhance adhesion, induce endothelial cel
l retraction, and increase experimental metastasis of tumor cells. Bec
ause of these prominent effects of exogenous 12(S)-HETE on tumor cell
metastatic potential, it is important to determine whether there is en
dogenous 12(S)-HETE production by tumor cells. In the present study, m
RNAs from human, rat, and mouse platelets as well as human colon carci
noma (Clone A), rat Walker carcinoma (W256), and mouse melanoma (B16a)
and lung carcinoma (3LL) were reverse transcribed and amplified by po
lymerase chain reaction with platelet 12-lipoxygenase specific primers
. Identity of the polymerase chain reaction fragments was confirmed by
sequencing. 12-lipoxygenase protein was detected by Western blotting.
Tumor cell-derived 12-HETE was determined by reverse phase-high perfo
rmance liquid chromatography analysis. In addition, the effect of endo
genous 12(S)-HETE on tumor cells was studied by using a platelet-type
12-lipoxygenase selective inhibitor (N-benzyl-N-hydroxy-5-phenylpentan
amide). Our results suggest that some tumor cells express platelet-ape
12-lipoxygenase mRNA, protein and metabolize arachidonic acid to 12(S
)-HETE and that endogenous 12(S)-HETE, like the exogenous 12(S)-HETE,
may play an important role in tumor cell adhesion to matrix in vitro a
nd lung colonization in vivo.